Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

YMTX

Yumanity Therapeutics (YMTX)

Yumanity Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:YMTX
FechaHoraFuenteTítuloSímboloCompañía
16/12/202213:58Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:YMTXYumanity Therapeutics Inc
16/12/202209:38Edgar (US Regulatory)Sec Staff Action/letter (sec Staff)NASDAQ:YMTXYumanity Therapeutics Inc
15/12/202205:43Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:YMTXYumanity Therapeutics Inc
06/12/202215:56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:YMTXYumanity Therapeutics Inc
06/12/202215:05Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:YMTXYumanity Therapeutics Inc
05/12/202206:30GlobeNewswire Inc.Yumanity Therapeutics Declares Special Dividend In Connection with Proposed Asset Sale to Janssen and Merger with KinetaNASDAQ:YMTXYumanity Therapeutics Inc
14/11/202207:45Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:YMTXYumanity Therapeutics Inc
14/11/202207:16GlobeNewswire Inc.Yumanity Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate DevelopmentsNASDAQ:YMTXYumanity Therapeutics Inc
14/11/202205:09Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:YMTXYumanity Therapeutics Inc
10/11/202215:27Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:YMTXYumanity Therapeutics Inc
10/11/202215:15GlobeNewswire Inc.Yumanity Therapeutics Announces Effectiveness of Registration Statement on Form S-4 In Connection With Proposed Asset Sale to Janssen and Merger with Kineta, Inc.NASDAQ:YMTXYumanity Therapeutics Inc
04/11/202215:53Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:YMTXYumanity Therapeutics Inc
29/08/202205:30GlobeNewswire Inc.Yumanity Therapeutics Announces Filing of Registration Statement on Form S-4 In Connection With Proposed Asset Sale to Janssen and Merger with KinetaNASDAQ:YMTXYumanity Therapeutics Inc
04/08/202215:15GlobeNewswire Inc.Yumanity Therapeutics Reports Second Quarter 2022 Financial Results and Recent Corporate DevelopmentsNASDAQ:YMTXYumanity Therapeutics Inc
06/06/202205:30GlobeNewswire Inc.Yumanity Therapeutics Announces Definitive Agreements for Two Strategic TransactionsNASDAQ:YMTXYumanity Therapeutics Inc
12/05/202215:45GlobeNewswire Inc.Yumanity Therapeutics Reports First Quarter 2022 Financial Results and Recent Corporate DevelopmentsNASDAQ:YMTXYumanity Therapeutics Inc
25/04/202215:04Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:YMTXYumanity Therapeutics Inc
25/04/202215:03Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:YMTXYumanity Therapeutics Inc
24/03/202215:36Edgar (US Regulatory)Annual Report (10-k)NASDAQ:YMTXYumanity Therapeutics Inc
24/03/202215:15GlobeNewswire Inc.Yumanity Therapeutics Reports Full-Year 2021 Financial Results and Recent Corporate DevelopmentsNASDAQ:YMTXYumanity Therapeutics Inc
17/02/202207:30GlobeNewswire Inc.Yumanity Therapeutics Exploring Strategic Alternatives to Enhance Shareholder Value and Announces RestructuringNASDAQ:YMTXYumanity Therapeutics Inc
14/02/202216:40Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:YMTXYumanity Therapeutics Inc
04/02/202217:48GlobeNewswire Inc.Yumanity Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:YMTXYumanity Therapeutics Inc
19/01/202206:30GlobeNewswire Inc.Yumanity Reports Partial Clinical Hold by U.S. FDA on Multidose Clinical Trials for YTX-7739  NASDAQ:YMTXYumanity Therapeutics Inc
11/01/202207:00GlobeNewswire Inc.Yumanity’s Approach to Neurodegenerative Diseases Validated by Two External CollaborationsNASDAQ:YMTXYumanity Therapeutics Inc
04/01/202207:00GlobeNewswire Inc.Yumanity Therapeutics to Present at the H.C. Wainwright BioConnect ConferenceNASDAQ:YMTXYumanity Therapeutics Inc
20/12/202115:03Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:YMTXYumanity Therapeutics Inc
03/12/202115:17Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:YMTXYumanity Therapeutics Inc
19/11/202115:56Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:YMTXYumanity Therapeutics Inc
16/11/202115:30GlobeNewswire Inc.Yumanity Therapeutics to Present at Multiple Upcoming November Investor ConferencesNASDAQ:YMTXYumanity Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:YMTX

Su Consulta Reciente

Delayed Upgrade Clock